Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
UTIL-01
i
Other names:
UTIL-01, Unmodified Tumour Infiltrating Lymphocytes, Unmodified TILs
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Instil Bio
Drug class:
T lymphocyte replacement
Related drugs:
‹
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
OBX-115 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
ThisCART22 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
MT-401 (0)
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
OBX-115 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
ThisCART22 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
MT-401 (0)
›
Associations
News
Trials
Filter by
Latest
almost4years
OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) (clinicaltrials.gov)
P1/2, N=0, Withdrawn, Immetacyte Ltd | N=22 --> 0 | Not yet recruiting --> Withdrawn
almost 4 years ago
Clinical • Enrollment change • Trial withdrawal
|
IL2 (Interleukin 2)
|
fludarabine IV • Proleukin (aldesleukin) • CoTIL-01 • UTIL-01 • cyclophosphamide intravenous
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login